nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—ALB—Tacrolimus—atopic dermatitis	0.0598	0.0844	CbGbCtD
Losartan—CYP2C8—Mometasone—atopic dermatitis	0.0589	0.0831	CbGbCtD
Losartan—CYP3A5—Tacrolimus—atopic dermatitis	0.0481	0.0678	CbGbCtD
Losartan—CYP2C8—Loratadine—atopic dermatitis	0.0338	0.0477	CbGbCtD
Losartan—CYP3A4—Pimecrolimus—atopic dermatitis	0.0315	0.0445	CbGbCtD
Losartan—ABCB1—Tacrolimus—atopic dermatitis	0.0313	0.0441	CbGbCtD
Losartan—CYP2C19—Loratadine—atopic dermatitis	0.0284	0.04	CbGbCtD
Losartan—CYP2C19—Diphenhydramine—atopic dermatitis	0.0284	0.04	CbGbCtD
Losartan—CYP1A2—Diphenhydramine—atopic dermatitis	0.0262	0.0369	CbGbCtD
Losartan—ALB—Prednisone—atopic dermatitis	0.0243	0.0342	CbGbCtD
Losartan—CYP2C9—Loratadine—atopic dermatitis	0.0236	0.0333	CbGbCtD
Losartan—CYP2C9—Diphenhydramine—atopic dermatitis	0.0236	0.0333	CbGbCtD
Losartan—ABCB1—Loratadine—atopic dermatitis	0.0229	0.0323	CbGbCtD
Losartan—ABCB1—Methylprednisolone—atopic dermatitis	0.021	0.0296	CbGbCtD
Losartan—CYP3A5—Hydrocortisone—atopic dermatitis	0.0196	0.0276	CbGbCtD
Losartan—CYP2C8—Hydrocortisone—atopic dermatitis	0.0188	0.0266	CbGbCtD
Losartan—CYP3A4—Tacrolimus—atopic dermatitis	0.0188	0.0264	CbGbCtD
Losartan—CYP2C19—Prednisone—atopic dermatitis	0.0157	0.0222	CbGbCtD
Losartan—CYP3A4—Loratadine—atopic dermatitis	0.0137	0.0194	CbGbCtD
Losartan—ABCB1—Betamethasone—atopic dermatitis	0.0136	0.0192	CbGbCtD
Losartan—ABCB1—Prednisolone—atopic dermatitis	0.0134	0.019	CbGbCtD
Losartan—ABCB1—Hydrocortisone—atopic dermatitis	0.0127	0.018	CbGbCtD
Losartan—ABCB1—Prednisone—atopic dermatitis	0.0127	0.0179	CbGbCtD
Losartan—CYP3A4—Methylprednisolone—atopic dermatitis	0.0126	0.0177	CbGbCtD
Losartan—CYP3A5—Dexamethasone—atopic dermatitis	0.0122	0.0172	CbGbCtD
Losartan—CYP2C8—Dexamethasone—atopic dermatitis	0.0117	0.0165	CbGbCtD
Losartan—CYP2C19—Dexamethasone—atopic dermatitis	0.00982	0.0139	CbGbCtD
Losartan—CYP3A4—Triamcinolone—atopic dermatitis	0.00952	0.0134	CbGbCtD
Losartan—CYP2C9—Dexamethasone—atopic dermatitis	0.00817	0.0115	CbGbCtD
Losartan—CYP3A4—Betamethasone—atopic dermatitis	0.00816	0.0115	CbGbCtD
Losartan—CYP3A4—Prednisolone—atopic dermatitis	0.00805	0.0114	CbGbCtD
Losartan—ABCB1—Dexamethasone—atopic dermatitis	0.00793	0.0112	CbGbCtD
Losartan—CYP3A4—Hydrocortisone—atopic dermatitis	0.00764	0.0108	CbGbCtD
Losartan—CYP3A4—Prednisone—atopic dermatitis	0.00761	0.0107	CbGbCtD
Losartan—CYP3A4—Dexamethasone—atopic dermatitis	0.00475	0.0067	CbGbCtD
Losartan—SLC2A9—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	0.000408	0.0147	CbGpPWpGaD
Losartan—AGTR1—Allograft Rejection—FOXP3—atopic dermatitis	0.000387	0.014	CbGpPWpGaD
Losartan—SLC22A12—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	0.000373	0.0135	CbGpPWpGaD
Losartan—AGTR1—Peptide GPCRs—CCR3—atopic dermatitis	0.00036	0.013	CbGpPWpGaD
Losartan—AGTR1—Allograft Rejection—IL13—atopic dermatitis	0.000331	0.0119	CbGpPWpGaD
Losartan—AGTR1—Peptide ligand-binding receptors—CCL22—atopic dermatitis	0.000322	0.0116	CbGpPWpGaD
Losartan—AGTR1—Peptide GPCRs—CXCR3—atopic dermatitis	0.000315	0.0114	CbGpPWpGaD
Losartan—AGTR1—Allograft Rejection—IL17A—atopic dermatitis	0.000304	0.011	CbGpPWpGaD
Losartan—AGTR1—Peptide ligand-binding receptors—CCL27—atopic dermatitis	0.000287	0.0104	CbGpPWpGaD
Losartan—AGTR1—Allograft Rejection—IL5—atopic dermatitis	0.000283	0.0102	CbGpPWpGaD
Losartan—AGTR1—Peptide ligand-binding receptors—CCL17—atopic dermatitis	0.000258	0.0093	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.000216	0.00781	CbGpPWpGaD
Losartan—AGTR1—Peptide ligand-binding receptors—CCL11—atopic dermatitis	0.000208	0.0075	CbGpPWpGaD
Losartan—SLC2A9—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.000207	0.00748	CbGpPWpGaD
Losartan—AGTR1—Allograft Rejection—IL10—atopic dermatitis	0.000207	0.00747	CbGpPWpGaD
Losartan—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—atopic dermatitis	0.000203	0.00731	CbGpPWpGaD
Losartan—AGTR1—Allograft Rejection—IL4—atopic dermatitis	0.000201	0.00727	CbGpPWpGaD
Losartan—AGTR1—Peptide GPCRs—CCR5—atopic dermatitis	0.000197	0.00712	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.000193	0.00696	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—GLB1—atopic dermatitis	0.000191	0.0069	CbGpPWpGaD
Losartan—SLC22A12—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.000189	0.00684	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—ADSL—atopic dermatitis	0.000183	0.00661	CbGpPWpGaD
Losartan—CYP1A2—Estrogen Receptor Pathway—PPARA—atopic dermatitis	0.000178	0.00643	CbGpPWpGaD
Losartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	0.000174	0.00627	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.000173	0.00624	CbGpPWpGaD
Losartan—SLCO1B3—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000173	0.00623	CbGpPWpGaD
Losartan—AGTR1—Peptide ligand-binding receptors—CCR3—atopic dermatitis	0.000169	0.00611	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—CCL22—atopic dermatitis	0.000165	0.00594	CbGpPWpGaD
Losartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	0.000155	0.00559	CbGpPWpGaD
Losartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	0.000154	0.00557	CbGpPWpGaD
Losartan—AGTR1—G alpha (q) signalling events—NPS—atopic dermatitis	0.000153	0.00552	CbGpPWpGaD
Losartan—AGTR1—G alpha (q) signalling events—TAC1—atopic dermatitis	0.000153	0.00552	CbGpPWpGaD
Losartan—AGTR1—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.000151	0.00545	CbGpPWpGaD
Losartan—AGTR1—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.000151	0.00545	CbGpPWpGaD
Losartan—AGTR1—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.000148	0.00534	CbGpPWpGaD
Losartan—Malaise—Triamcinolone—atopic dermatitis	0.000148	0.000562	CcSEcCtD
Losartan—Anxiety—Hydrocortisone—atopic dermatitis	0.000148	0.000562	CcSEcCtD
Losartan—Malaise—Methylprednisolone—atopic dermatitis	0.000148	0.000561	CcSEcCtD
Losartan—ACE—Metabolism of proteins—GLB1—atopic dermatitis	0.000148	0.00533	CbGpPWpGaD
Losartan—Vertigo—Triamcinolone—atopic dermatitis	0.000147	0.00056	CcSEcCtD
Losartan—Syncope—Triamcinolone—atopic dermatitis	0.000147	0.000559	CcSEcCtD
Losartan—Vertigo—Methylprednisolone—atopic dermatitis	0.000147	0.000559	CcSEcCtD
Losartan—Syncope—Methylprednisolone—atopic dermatitis	0.000147	0.000558	CcSEcCtD
Losartan—AGTR1—GPCR ligand binding—CCL27—atopic dermatitis	0.000147	0.0053	CbGpPWpGaD
Losartan—Discomfort—Hydrocortisone—atopic dermatitis	0.000147	0.000557	CcSEcCtD
Losartan—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000146	0.000553	CcSEcCtD
Losartan—Oedema—Prednisolone—atopic dermatitis	0.000146	0.000553	CcSEcCtD
Losartan—Vomiting—Tacrolimus—atopic dermatitis	0.000145	0.000551	CcSEcCtD
Losartan—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000144	0.000548	CcSEcCtD
Losartan—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000144	0.000547	CcSEcCtD
Losartan—Rash—Tacrolimus—atopic dermatitis	0.000144	0.000546	CcSEcCtD
Losartan—Dermatitis—Tacrolimus—atopic dermatitis	0.000144	0.000546	CcSEcCtD
Losartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MAPK8—atopic dermatitis	0.000144	0.00518	CbGpPWpGaD
Losartan—Shock—Prednisolone—atopic dermatitis	0.000143	0.000544	CcSEcCtD
Losartan—Cough—Triamcinolone—atopic dermatitis	0.000143	0.000544	CcSEcCtD
Losartan—AGTR1—Allograft Rejection—CASP8—atopic dermatitis	0.000143	0.00517	CbGpPWpGaD
Losartan—Headache—Tacrolimus—atopic dermatitis	0.000143	0.000543	CcSEcCtD
Losartan—Oedema—Hydrocortisone—atopic dermatitis	0.000142	0.00054	CcSEcCtD
Losartan—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000142	0.00054	CcSEcCtD
Losartan—Tachycardia—Prednisolone—atopic dermatitis	0.000142	0.00054	CcSEcCtD
Losartan—Infection—Hydrocortisone—atopic dermatitis	0.000141	0.000537	CcSEcCtD
Losartan—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000141	0.000535	CcSEcCtD
Losartan—Shock—Hydrocortisone—atopic dermatitis	0.00014	0.000532	CcSEcCtD
Losartan—Myalgia—Triamcinolone—atopic dermatitis	0.00014	0.000531	CcSEcCtD
Losartan—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000139	0.00053	CcSEcCtD
Losartan—Arthralgia—Methylprednisolone—atopic dermatitis	0.000139	0.00053	CcSEcCtD
Losartan—Myalgia—Methylprednisolone—atopic dermatitis	0.000139	0.00053	CcSEcCtD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000139	0.00503	CbGpPWpGaD
Losartan—Anxiety—Methylprednisolone—atopic dermatitis	0.000139	0.000528	CcSEcCtD
Losartan—Tachycardia—Hydrocortisone—atopic dermatitis	0.000139	0.000527	CcSEcCtD
Losartan—Flushing—Prednisone—atopic dermatitis	0.000138	0.000525	CcSEcCtD
Losartan—Ill-defined disorder—Dexamethasone—atopic dermatitis	0.000138	0.000525	CcSEcCtD
Losartan—Ill-defined disorder—Betamethasone—atopic dermatitis	0.000138	0.000525	CcSEcCtD
Losartan—Discomfort—Triamcinolone—atopic dermatitis	0.000138	0.000524	CcSEcCtD
Losartan—Discomfort—Methylprednisolone—atopic dermatitis	0.000138	0.000523	CcSEcCtD
Losartan—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000137	0.000522	CcSEcCtD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.000137	0.00494	CbGpPWpGaD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.000137	0.00494	CbGpPWpGaD
Losartan—Dry mouth—Triamcinolone—atopic dermatitis	0.000137	0.000519	CcSEcCtD
Losartan—Angioedema—Dexamethasone—atopic dermatitis	0.000136	0.000517	CcSEcCtD
Losartan—Angioedema—Betamethasone—atopic dermatitis	0.000136	0.000517	CcSEcCtD
Losartan—Anorexia—Hydrocortisone—atopic dermatitis	0.000136	0.000515	CcSEcCtD
Losartan—Nausea—Tacrolimus—atopic dermatitis	0.000135	0.000515	CcSEcCtD
Losartan—Angiopathy—Prednisone—atopic dermatitis	0.000135	0.000513	CcSEcCtD
Losartan—Confusional state—Methylprednisolone—atopic dermatitis	0.000135	0.000512	CcSEcCtD
Losartan—Malaise—Betamethasone—atopic dermatitis	0.000134	0.00051	CcSEcCtD
Losartan—Malaise—Dexamethasone—atopic dermatitis	0.000134	0.00051	CcSEcCtD
Losartan—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000134	0.000509	CcSEcCtD
Losartan—Oedema—Triamcinolone—atopic dermatitis	0.000134	0.000509	CcSEcCtD
Losartan—Vertigo—Dexamethasone—atopic dermatitis	0.000134	0.000508	CcSEcCtD
Losartan—Vertigo—Betamethasone—atopic dermatitis	0.000134	0.000508	CcSEcCtD
Losartan—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000134	0.000508	CcSEcCtD
Losartan—Syncope—Dexamethasone—atopic dermatitis	0.000134	0.000507	CcSEcCtD
Losartan—Syncope—Betamethasone—atopic dermatitis	0.000134	0.000507	CcSEcCtD
Losartan—Arrhythmia—Prednisone—atopic dermatitis	0.000133	0.000506	CcSEcCtD
Losartan—Infection—Triamcinolone—atopic dermatitis	0.000133	0.000505	CcSEcCtD
Losartan—Hypotension—Hydrocortisone—atopic dermatitis	0.000133	0.000505	CcSEcCtD
Losartan—Infection—Methylprednisolone—atopic dermatitis	0.000133	0.000504	CcSEcCtD
Losartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000133	0.00479	CbGpPWpGaD
Losartan—Shock—Triamcinolone—atopic dermatitis	0.000132	0.000501	CcSEcCtD
Losartan—Insomnia—Prednisolone—atopic dermatitis	0.000132	0.0005	CcSEcCtD
Losartan—Alopecia—Prednisone—atopic dermatitis	0.000132	0.0005	CcSEcCtD
Losartan—AGTR1—GPCR ligand binding—CCL17—atopic dermatitis	0.000132	0.00475	CbGpPWpGaD
Losartan—Shock—Methylprednisolone—atopic dermatitis	0.000131	0.000499	CcSEcCtD
Losartan—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000131	0.000498	CcSEcCtD
Losartan—Loss of consciousness—Betamethasone—atopic dermatitis	0.000131	0.000497	CcSEcCtD
Losartan—Loss of consciousness—Dexamethasone—atopic dermatitis	0.000131	0.000497	CcSEcCtD
Losartan—Paraesthesia—Prednisolone—atopic dermatitis	0.000131	0.000497	CcSEcCtD
Losartan—Tachycardia—Triamcinolone—atopic dermatitis	0.000131	0.000497	CcSEcCtD
Losartan—Tachycardia—Methylprednisolone—atopic dermatitis	0.00013	0.000495	CcSEcCtD
Losartan—Erythema—Prednisone—atopic dermatitis	0.00013	0.000493	CcSEcCtD
Losartan—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.00013	0.000492	CcSEcCtD
Losartan—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000129	0.000492	CcSEcCtD
Losartan—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000129	0.000491	CcSEcCtD
Losartan—Insomnia—Hydrocortisone—atopic dermatitis	0.000129	0.000489	CcSEcCtD
Losartan—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000128	0.000485	CcSEcCtD
Losartan—SLC22A6—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000127	0.0046	CbGpPWpGaD
Losartan—Myalgia—Betamethasone—atopic dermatitis	0.000127	0.000482	CcSEcCtD
Losartan—Myalgia—Dexamethasone—atopic dermatitis	0.000127	0.000482	CcSEcCtD
Losartan—Anxiety—Dexamethasone—atopic dermatitis	0.000126	0.00048	CcSEcCtD
Losartan—Anxiety—Betamethasone—atopic dermatitis	0.000126	0.00048	CcSEcCtD
Losartan—Discomfort—Dexamethasone—atopic dermatitis	0.000125	0.000476	CcSEcCtD
Losartan—Discomfort—Betamethasone—atopic dermatitis	0.000125	0.000476	CcSEcCtD
Losartan—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000125	0.000476	CcSEcCtD
Losartan—Hypotension—Methylprednisolone—atopic dermatitis	0.000125	0.000474	CcSEcCtD
Losartan—SLCO1B3—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	0.000125	0.0045	CbGpPWpGaD
Losartan—Pain—Prednisolone—atopic dermatitis	0.000125	0.000473	CcSEcCtD
Losartan—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000124	0.00047	CcSEcCtD
Losartan—Fatigue—Hydrocortisone—atopic dermatitis	0.000123	0.000466	CcSEcCtD
Losartan—Vision blurred—Prednisone—atopic dermatitis	0.000122	0.000464	CcSEcCtD
Losartan—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000122	0.000464	CcSEcCtD
Losartan—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000122	0.000463	CcSEcCtD
Losartan—AGTR1—Allograft Rejection—IFNG—atopic dermatitis	0.000122	0.00439	CbGpPWpGaD
Losartan—Pain—Hydrocortisone—atopic dermatitis	0.000122	0.000462	CcSEcCtD
Losartan—Oedema—Betamethasone—atopic dermatitis	0.000121	0.000462	CcSEcCtD
Losartan—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000121	0.000462	CcSEcCtD
Losartan—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000121	0.000462	CcSEcCtD
Losartan—Oedema—Dexamethasone—atopic dermatitis	0.000121	0.000462	CcSEcCtD
Losartan—Insomnia—Triamcinolone—atopic dermatitis	0.000121	0.00046	CcSEcCtD
Losartan—Insomnia—Methylprednisolone—atopic dermatitis	0.000121	0.000459	CcSEcCtD
Losartan—Infection—Betamethasone—atopic dermatitis	0.000121	0.000459	CcSEcCtD
Losartan—Infection—Dexamethasone—atopic dermatitis	0.000121	0.000459	CcSEcCtD
Losartan—Ill-defined disorder—Prednisone—atopic dermatitis	0.00012	0.000457	CcSEcCtD
Losartan—Paraesthesia—Triamcinolone—atopic dermatitis	0.00012	0.000457	CcSEcCtD
Losartan—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	0.00012	0.00433	CbGpPWpGaD
Losartan—Feeling abnormal—Prednisolone—atopic dermatitis	0.00012	0.000456	CcSEcCtD
Losartan—Paraesthesia—Methylprednisolone—atopic dermatitis	0.00012	0.000456	CcSEcCtD
Losartan—Anaemia—Prednisone—atopic dermatitis	0.00012	0.000455	CcSEcCtD
Losartan—AGTR1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.00012	0.00432	CbGpPWpGaD
Losartan—Shock—Betamethasone—atopic dermatitis	0.00012	0.000454	CcSEcCtD
Losartan—Shock—Dexamethasone—atopic dermatitis	0.00012	0.000454	CcSEcCtD
Losartan—Dyspnoea—Triamcinolone—atopic dermatitis	0.000119	0.000454	CcSEcCtD
Losartan—Nervous system disorder—Betamethasone—atopic dermatitis	0.000119	0.000453	CcSEcCtD
Losartan—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000119	0.000453	CcSEcCtD
Losartan—Agitation—Prednisone—atopic dermatitis	0.000119	0.000453	CcSEcCtD
Losartan—Thrombocytopenia—Betamethasone—atopic dermatitis	0.000119	0.000452	CcSEcCtD
Losartan—Thrombocytopenia—Dexamethasone—atopic dermatitis	0.000119	0.000452	CcSEcCtD
Losartan—Tachycardia—Dexamethasone—atopic dermatitis	0.000119	0.000451	CcSEcCtD
Losartan—Tachycardia—Betamethasone—atopic dermatitis	0.000119	0.000451	CcSEcCtD
Losartan—Angioedema—Prednisone—atopic dermatitis	0.000118	0.00045	CcSEcCtD
Losartan—Dyspepsia—Triamcinolone—atopic dermatitis	0.000118	0.000448	CcSEcCtD
Losartan—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000118	0.000447	CcSEcCtD
Losartan—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000117	0.000446	CcSEcCtD
Losartan—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000117	0.000446	CcSEcCtD
Losartan—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000117	0.000445	CcSEcCtD
Losartan—Malaise—Prednisone—atopic dermatitis	0.000117	0.000444	CcSEcCtD
Losartan—Vertigo—Prednisone—atopic dermatitis	0.000116	0.000443	CcSEcCtD
Losartan—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000116	0.000442	CcSEcCtD
Losartan—Syncope—Prednisone—atopic dermatitis	0.000116	0.000442	CcSEcCtD
Losartan—SLCO1B1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000116	0.00419	CbGpPWpGaD
Losartan—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000116	0.00418	CbGpPWpGaD
Losartan—Anorexia—Dexamethasone—atopic dermatitis	0.000116	0.00044	CcSEcCtD
Losartan—Anorexia—Betamethasone—atopic dermatitis	0.000116	0.00044	CcSEcCtD
Losartan—Urticaria—Prednisolone—atopic dermatitis	0.000116	0.00044	CcSEcCtD
Losartan—Fatigue—Triamcinolone—atopic dermatitis	0.000115	0.000439	CcSEcCtD
Losartan—Fatigue—Methylprednisolone—atopic dermatitis	0.000115	0.000438	CcSEcCtD
Losartan—Pain—Triamcinolone—atopic dermatitis	0.000115	0.000435	CcSEcCtD
Losartan—Loss of consciousness—Prednisone—atopic dermatitis	0.000114	0.000433	CcSEcCtD
Losartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—atopic dermatitis	0.000114	0.0041	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000114	0.0041	CbGpPWpGaD
Losartan—Hypotension—Betamethasone—atopic dermatitis	0.000114	0.000431	CcSEcCtD
Losartan—Hypotension—Dexamethasone—atopic dermatitis	0.000114	0.000431	CcSEcCtD
Losartan—ABCB1—Allograft Rejection—FOXP3—atopic dermatitis	0.000114	0.0041	CbGpPWpGaD
Losartan—AGTR1—Allograft Rejection—CXCL8—atopic dermatitis	0.000113	0.00409	CbGpPWpGaD
Losartan—Urticaria—Hydrocortisone—atopic dermatitis	0.000113	0.000429	CcSEcCtD
Losartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	0.000112	0.00406	CbGpPWpGaD
Losartan—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000112	0.000427	CcSEcCtD
Losartan—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000112	0.000427	CcSEcCtD
Losartan—ACE—Metabolism of proteins—CMA1—atopic dermatitis	0.000112	0.00404	CbGpPWpGaD
Losartan—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000111	0.000421	CcSEcCtD
Losartan—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000111	0.000421	CcSEcCtD
Losartan—Myalgia—Prednisone—atopic dermatitis	0.00011	0.000419	CcSEcCtD
Losartan—Arthralgia—Prednisone—atopic dermatitis	0.00011	0.000419	CcSEcCtD
Losartan—Feeling abnormal—Triamcinolone—atopic dermatitis	0.00011	0.000419	CcSEcCtD
Losartan—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.00011	0.000418	CcSEcCtD
Losartan—Anxiety—Prednisone—atopic dermatitis	0.00011	0.000418	CcSEcCtD
Losartan—Insomnia—Betamethasone—atopic dermatitis	0.00011	0.000418	CcSEcCtD
Losartan—Insomnia—Dexamethasone—atopic dermatitis	0.00011	0.000418	CcSEcCtD
Losartan—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000109	0.000415	CcSEcCtD
Losartan—Paraesthesia—Betamethasone—atopic dermatitis	0.000109	0.000415	CcSEcCtD
Losartan—Paraesthesia—Dexamethasone—atopic dermatitis	0.000109	0.000415	CcSEcCtD
Losartan—Discomfort—Prednisone—atopic dermatitis	0.000109	0.000414	CcSEcCtD
Losartan—AGTR1—Allograft Rejection—IL1B—atopic dermatitis	0.000109	0.00392	CbGpPWpGaD
Losartan—AGTR1—Allograft Rejection—IL2—atopic dermatitis	0.000108	0.00391	CbGpPWpGaD
Losartan—Hypersensitivity—Prednisolone—atopic dermatitis	0.000107	0.000408	CcSEcCtD
Losartan—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	0.000107	0.00387	CbGpPWpGaD
Losartan—Dyspepsia—Dexamethasone—atopic dermatitis	0.000107	0.000406	CcSEcCtD
Losartan—Dyspepsia—Betamethasone—atopic dermatitis	0.000107	0.000406	CcSEcCtD
Losartan—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	0.000107	0.00385	CbGpPWpGaD
Losartan—Urticaria—Triamcinolone—atopic dermatitis	0.000106	0.000404	CcSEcCtD
Losartan—Urticaria—Methylprednisolone—atopic dermatitis	0.000106	0.000403	CcSEcCtD
Losartan—AGTR1—GPCR ligand binding—CCL11—atopic dermatitis	0.000106	0.00383	CbGpPWpGaD
Losartan—Body temperature increased—Triamcinolone—atopic dermatitis	0.000106	0.000402	CcSEcCtD
Losartan—Oedema—Prednisone—atopic dermatitis	0.000106	0.000402	CcSEcCtD
Losartan—Anaphylactic shock—Prednisone—atopic dermatitis	0.000106	0.000402	CcSEcCtD
Losartan—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000106	0.000401	CcSEcCtD
Losartan—Decreased appetite—Betamethasone—atopic dermatitis	0.000106	0.000401	CcSEcCtD
Losartan—Decreased appetite—Dexamethasone—atopic dermatitis	0.000106	0.000401	CcSEcCtD
Losartan—Infection—Prednisone—atopic dermatitis	0.000105	0.000399	CcSEcCtD
Losartan—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000105	0.000398	CcSEcCtD
Losartan—Fatigue—Dexamethasone—atopic dermatitis	0.000105	0.000398	CcSEcCtD
Losartan—Fatigue—Betamethasone—atopic dermatitis	0.000105	0.000398	CcSEcCtD
Losartan—Shock—Prednisone—atopic dermatitis	0.000104	0.000396	CcSEcCtD
Losartan—Pain—Dexamethasone—atopic dermatitis	0.000104	0.000395	CcSEcCtD
Losartan—Pain—Betamethasone—atopic dermatitis	0.000104	0.000395	CcSEcCtD
Losartan—Nervous system disorder—Prednisone—atopic dermatitis	0.000104	0.000394	CcSEcCtD
Losartan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000103	0.00373	CbGpPWpGaD
Losartan—Tachycardia—Prednisone—atopic dermatitis	0.000103	0.000392	CcSEcCtD
Losartan—AGTR1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000103	0.00372	CbGpPWpGaD
Losartan—Hyperhidrosis—Prednisone—atopic dermatitis	0.000102	0.000389	CcSEcCtD
Losartan—Asthenia—Hydrocortisone—atopic dermatitis	0.000102	0.000388	CcSEcCtD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000101	0.00365	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000101	0.00365	CbGpPWpGaD
Losartan—Anorexia—Prednisone—atopic dermatitis	0.000101	0.000383	CcSEcCtD
Losartan—Pruritus—Hydrocortisone—atopic dermatitis	0.000101	0.000382	CcSEcCtD
Losartan—SLC2A9—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.0001	0.00362	CbGpPWpGaD
Losartan—Feeling abnormal—Betamethasone—atopic dermatitis	0.0001	0.00038	CcSEcCtD
Losartan—Feeling abnormal—Dexamethasone—atopic dermatitis	0.0001	0.00038	CcSEcCtD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	9.94e-05	0.00359	CbGpPWpGaD
Losartan—Gastrointestinal pain—Dexamethasone—atopic dermatitis	9.94e-05	0.000378	CcSEcCtD
Losartan—Gastrointestinal pain—Betamethasone—atopic dermatitis	9.94e-05	0.000378	CcSEcCtD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	9.93e-05	0.00358	CbGpPWpGaD
Losartan—ALB—Vitamin B12 Metabolism—CCL5—atopic dermatitis	9.88e-05	0.00357	CbGpPWpGaD
Losartan—Hypersensitivity—Triamcinolone—atopic dermatitis	9.87e-05	0.000375	CcSEcCtD
Losartan—Hypersensitivity—Methylprednisolone—atopic dermatitis	9.84e-05	0.000374	CcSEcCtD
Losartan—Diarrhoea—Hydrocortisone—atopic dermatitis	9.73e-05	0.00037	CcSEcCtD
Losartan—ABCB1—Allograft Rejection—IL13—atopic dermatitis	9.71e-05	0.00351	CbGpPWpGaD
Losartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	9.66e-05	0.00349	CbGpPWpGaD
Losartan—Urticaria—Dexamethasone—atopic dermatitis	9.65e-05	0.000367	CcSEcCtD
Losartan—Urticaria—Betamethasone—atopic dermatitis	9.65e-05	0.000367	CcSEcCtD
Losartan—Musculoskeletal discomfort—Prednisone—atopic dermatitis	9.64e-05	0.000366	CcSEcCtD
Losartan—Dizziness—Prednisolone—atopic dermatitis	9.63e-05	0.000366	CcSEcCtD
Losartan—Asthenia—Triamcinolone—atopic dermatitis	9.61e-05	0.000365	CcSEcCtD
Losartan—Abdominal pain—Betamethasone—atopic dermatitis	9.6e-05	0.000365	CcSEcCtD
Losartan—Abdominal pain—Dexamethasone—atopic dermatitis	9.6e-05	0.000365	CcSEcCtD
Losartan—Body temperature increased—Dexamethasone—atopic dermatitis	9.6e-05	0.000365	CcSEcCtD
Losartan—Body temperature increased—Betamethasone—atopic dermatitis	9.6e-05	0.000365	CcSEcCtD
Losartan—Asthenia—Methylprednisolone—atopic dermatitis	9.59e-05	0.000364	CcSEcCtD
Losartan—Insomnia—Prednisone—atopic dermatitis	9.57e-05	0.000364	CcSEcCtD
Losartan—Paraesthesia—Prednisone—atopic dermatitis	9.5e-05	0.000361	CcSEcCtD
Losartan—Pruritus—Triamcinolone—atopic dermatitis	9.47e-05	0.00036	CcSEcCtD
Losartan—Pruritus—Methylprednisolone—atopic dermatitis	9.45e-05	0.000359	CcSEcCtD
Losartan—Dizziness—Hydrocortisone—atopic dermatitis	9.4e-05	0.000357	CcSEcCtD
Losartan—Dyspepsia—Prednisone—atopic dermatitis	9.31e-05	0.000354	CcSEcCtD
Losartan—AGTR1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	9.28e-05	0.00335	CbGpPWpGaD
Losartan—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	9.2e-05	0.00332	CbGpPWpGaD
Losartan—Decreased appetite—Prednisone—atopic dermatitis	9.2e-05	0.000349	CcSEcCtD
Losartan—Rash—Prednisolone—atopic dermatitis	9.18e-05	0.000349	CcSEcCtD
Losartan—SLC22A12—Transmembrane transport of small molecules—PPARA—atopic dermatitis	9.18e-05	0.00331	CbGpPWpGaD
Losartan—Dermatitis—Prednisolone—atopic dermatitis	9.17e-05	0.000349	CcSEcCtD
Losartan—Diarrhoea—Methylprednisolone—atopic dermatitis	9.14e-05	0.000347	CcSEcCtD
Losartan—Fatigue—Prednisone—atopic dermatitis	9.12e-05	0.000347	CcSEcCtD
Losartan—Headache—Prednisolone—atopic dermatitis	9.12e-05	0.000347	CcSEcCtD
Losartan—Constipation—Prednisone—atopic dermatitis	9.05e-05	0.000344	CcSEcCtD
Losartan—Vomiting—Hydrocortisone—atopic dermatitis	9.04e-05	0.000344	CcSEcCtD
Losartan—Rash—Hydrocortisone—atopic dermatitis	8.97e-05	0.000341	CcSEcCtD
Losartan—Dermatitis—Hydrocortisone—atopic dermatitis	8.96e-05	0.00034	CcSEcCtD
Losartan—ABCB1—Allograft Rejection—IL17A—atopic dermatitis	8.94e-05	0.00323	CbGpPWpGaD
Losartan—Headache—Hydrocortisone—atopic dermatitis	8.91e-05	0.000339	CcSEcCtD
Losartan—Dizziness—Triamcinolone—atopic dermatitis	8.85e-05	0.000336	CcSEcCtD
Losartan—Dizziness—Methylprednisolone—atopic dermatitis	8.83e-05	0.000336	CcSEcCtD
Losartan—Feeling abnormal—Prednisone—atopic dermatitis	8.72e-05	0.000331	CcSEcCtD
Losartan—Asthenia—Dexamethasone—atopic dermatitis	8.72e-05	0.000331	CcSEcCtD
Losartan—Asthenia—Betamethasone—atopic dermatitis	8.72e-05	0.000331	CcSEcCtD
Losartan—Gastrointestinal pain—Prednisone—atopic dermatitis	8.65e-05	0.000329	CcSEcCtD
Losartan—Nausea—Prednisolone—atopic dermatitis	8.65e-05	0.000329	CcSEcCtD
Losartan—AGTR1—GPCR ligand binding—CCR3—atopic dermatitis	8.65e-05	0.00312	CbGpPWpGaD
Losartan—Pruritus—Betamethasone—atopic dermatitis	8.6e-05	0.000327	CcSEcCtD
Losartan—Pruritus—Dexamethasone—atopic dermatitis	8.6e-05	0.000327	CcSEcCtD
Losartan—Vomiting—Triamcinolone—atopic dermatitis	8.51e-05	0.000324	CcSEcCtD
Losartan—Vomiting—Methylprednisolone—atopic dermatitis	8.49e-05	0.000323	CcSEcCtD
Losartan—AGTR1—Signaling by GPCR—CCL22—atopic dermatitis	8.45e-05	0.00305	CbGpPWpGaD
Losartan—Nausea—Hydrocortisone—atopic dermatitis	8.45e-05	0.000321	CcSEcCtD
Losartan—Rash—Triamcinolone—atopic dermatitis	8.44e-05	0.000321	CcSEcCtD
Losartan—Dermatitis—Triamcinolone—atopic dermatitis	8.44e-05	0.000321	CcSEcCtD
Losartan—Rash—Methylprednisolone—atopic dermatitis	8.42e-05	0.00032	CcSEcCtD
Losartan—Dermatitis—Methylprednisolone—atopic dermatitis	8.42e-05	0.00032	CcSEcCtD
Losartan—Urticaria—Prednisone—atopic dermatitis	8.41e-05	0.000319	CcSEcCtD
Losartan—Headache—Triamcinolone—atopic dermatitis	8.39e-05	0.000319	CcSEcCtD
Losartan—SLCO1B1—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	8.37e-05	0.00302	CbGpPWpGaD
Losartan—Headache—Methylprednisolone—atopic dermatitis	8.37e-05	0.000318	CcSEcCtD
Losartan—Body temperature increased—Prednisone—atopic dermatitis	8.36e-05	0.000318	CcSEcCtD
Losartan—Abdominal pain—Prednisone—atopic dermatitis	8.36e-05	0.000318	CcSEcCtD
Losartan—Diarrhoea—Dexamethasone—atopic dermatitis	8.31e-05	0.000316	CcSEcCtD
Losartan—Diarrhoea—Betamethasone—atopic dermatitis	8.31e-05	0.000316	CcSEcCtD
Losartan—ABCB1—Allograft Rejection—IL5—atopic dermatitis	8.31e-05	0.003	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—CCL27—atopic dermatitis	8.29e-05	0.00299	CbGpPWpGaD
Losartan—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	8.25e-05	0.00298	CbGpPWpGaD
Losartan—Dizziness—Dexamethasone—atopic dermatitis	8.03e-05	0.000305	CcSEcCtD
Losartan—Dizziness—Betamethasone—atopic dermatitis	8.03e-05	0.000305	CcSEcCtD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	8.02e-05	0.0029	CbGpPWpGaD
Losartan—Nausea—Triamcinolone—atopic dermatitis	7.95e-05	0.000302	CcSEcCtD
Losartan—Nausea—Methylprednisolone—atopic dermatitis	7.94e-05	0.000302	CcSEcCtD
Losartan—AGTR1—Allograft Rejection—TNF—atopic dermatitis	7.88e-05	0.00284	CbGpPWpGaD
Losartan—Hypersensitivity—Prednisone—atopic dermatitis	7.8e-05	0.000296	CcSEcCtD
Losartan—ALB—Folate Metabolism—IL4—atopic dermatitis	7.79e-05	0.00281	CbGpPWpGaD
Losartan—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	7.77e-05	0.0028	CbGpPWpGaD
Losartan—Vomiting—Betamethasone—atopic dermatitis	7.72e-05	0.000294	CcSEcCtD
Losartan—Vomiting—Dexamethasone—atopic dermatitis	7.72e-05	0.000294	CcSEcCtD
Losartan—AGTR1—GPCR ligand binding—TAC1—atopic dermatitis	7.71e-05	0.00278	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—NPS—atopic dermatitis	7.71e-05	0.00278	CbGpPWpGaD
Losartan—Rash—Betamethasone—atopic dermatitis	7.66e-05	0.000291	CcSEcCtD
Losartan—Rash—Dexamethasone—atopic dermatitis	7.66e-05	0.000291	CcSEcCtD
Losartan—Dermatitis—Dexamethasone—atopic dermatitis	7.65e-05	0.000291	CcSEcCtD
Losartan—Dermatitis—Betamethasone—atopic dermatitis	7.65e-05	0.000291	CcSEcCtD
Losartan—Headache—Dexamethasone—atopic dermatitis	7.61e-05	0.000289	CcSEcCtD
Losartan—Headache—Betamethasone—atopic dermatitis	7.61e-05	0.000289	CcSEcCtD
Losartan—Asthenia—Prednisone—atopic dermatitis	7.59e-05	0.000288	CcSEcCtD
Losartan—AGTR1—GPCR ligand binding—CXCR3—atopic dermatitis	7.56e-05	0.00273	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—CCL27—atopic dermatitis	7.53e-05	0.00272	CbGpPWpGaD
Losartan—Pruritus—Prednisone—atopic dermatitis	7.49e-05	0.000284	CcSEcCtD
Losartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	7.26e-05	0.00262	CbGpPWpGaD
Losartan—Diarrhoea—Prednisone—atopic dermatitis	7.24e-05	0.000275	CcSEcCtD
Losartan—Nausea—Dexamethasone—atopic dermatitis	7.22e-05	0.000274	CcSEcCtD
Losartan—Nausea—Betamethasone—atopic dermatitis	7.22e-05	0.000274	CcSEcCtD
Losartan—Dizziness—Prednisone—atopic dermatitis	7e-05	0.000266	CcSEcCtD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	6.91e-05	0.00249	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—CCL17—atopic dermatitis	6.75e-05	0.00244	CbGpPWpGaD
Losartan—Vomiting—Prednisone—atopic dermatitis	6.73e-05	0.000256	CcSEcCtD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	6.68e-05	0.00241	CbGpPWpGaD
Losartan—Rash—Prednisone—atopic dermatitis	6.67e-05	0.000253	CcSEcCtD
Losartan—Dermatitis—Prednisone—atopic dermatitis	6.67e-05	0.000253	CcSEcCtD
Losartan—Headache—Prednisone—atopic dermatitis	6.63e-05	0.000252	CcSEcCtD
Losartan—ALB—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	6.62e-05	0.00239	CbGpPWpGaD
Losartan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	6.37e-05	0.0023	CbGpPWpGaD
Losartan—SLCO1B3—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	6.33e-05	0.00229	CbGpPWpGaD
Losartan—Nausea—Prednisone—atopic dermatitis	6.28e-05	0.000239	CcSEcCtD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	6.22e-05	0.00225	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—PPARA—atopic dermatitis	6.2e-05	0.00224	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—CXCL10—atopic dermatitis	6.11e-05	0.00221	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—IL10—atopic dermatitis	6.07e-05	0.00219	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—IL4—atopic dermatitis	5.91e-05	0.00213	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	5.8e-05	0.0021	CbGpPWpGaD
Losartan—ALB—Vitamin B12 Metabolism—IFNG—atopic dermatitis	5.79e-05	0.00209	CbGpPWpGaD
Losartan—AGTR1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	5.61e-05	0.00203	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—CCL11—atopic dermatitis	5.44e-05	0.00197	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—FCER2—atopic dermatitis	5.37e-05	0.00194	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—CCL5—atopic dermatitis	5.26e-05	0.0019	CbGpPWpGaD
Losartan—ALB—Vitamin B12 Metabolism—IL1B—atopic dermatitis	5.16e-05	0.00186	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CCL22—atopic dermatitis	4.99e-05	0.0018	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—CCR3—atopic dermatitis	4.89e-05	0.00176	CbGpPWpGaD
Losartan—ALB—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	4.78e-05	0.00173	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—CCR5—atopic dermatitis	4.74e-05	0.00171	CbGpPWpGaD
Losartan—ALB—Folate Metabolism—IFNG—atopic dermatitis	4.71e-05	0.0017	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—GLB1—atopic dermatitis	4.7e-05	0.0017	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	4.68e-05	0.00169	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—ADSL—atopic dermatitis	4.5e-05	0.00163	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CCL27—atopic dermatitis	4.45e-05	0.00161	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—CCR3—atopic dermatitis	4.44e-05	0.0016	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—GLB1—atopic dermatitis	4.43e-05	0.0016	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	4.39e-05	0.00159	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—TAC1—atopic dermatitis	4.36e-05	0.00157	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—NPS—atopic dermatitis	4.36e-05	0.00157	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—CXCR3—atopic dermatitis	4.27e-05	0.00154	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	4.26e-05	0.00154	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—ADSL—atopic dermatitis	4.25e-05	0.00153	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—CASP8—atopic dermatitis	4.2e-05	0.00152	CbGpPWpGaD
Losartan—ALB—Folate Metabolism—IL1B—atopic dermatitis	4.2e-05	0.00152	CbGpPWpGaD
Losartan—ALB—Folate Metabolism—IL2—atopic dermatitis	4.18e-05	0.00151	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—IL5—atopic dermatitis	4.16e-05	0.0015	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—IL5—atopic dermatitis	4.05e-05	0.00146	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—GLB1—atopic dermatitis	4e-05	0.00144	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CCL17—atopic dermatitis	3.99e-05	0.00144	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—TAC1—atopic dermatitis	3.96e-05	0.00143	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—NPS—atopic dermatitis	3.96e-05	0.00143	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	3.92e-05	0.00142	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	3.91e-05	0.00141	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—CXCR3—atopic dermatitis	3.88e-05	0.0014	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	3.84e-05	0.00139	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—ADSL—atopic dermatitis	3.83e-05	0.00138	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	3.82e-05	0.00138	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.76e-05	0.00136	CbGpPWpGaD
Losartan—ALB—Vitamin B12 Metabolism—TNF—atopic dermatitis	3.74e-05	0.00135	CbGpPWpGaD
Losartan—ALB—Selenium Micronutrient Network—IFNG—atopic dermatitis	3.74e-05	0.00135	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—IL5—atopic dermatitis	3.68e-05	0.00133	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—IFNG—atopic dermatitis	3.57e-05	0.00129	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—KIF3A—atopic dermatitis	3.56e-05	0.00128	CbGpPWpGaD
Losartan—ALB—Hemostasis—KIF3A—atopic dermatitis	3.51e-05	0.00127	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—CXCL10—atopic dermatitis	3.45e-05	0.00125	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	3.43e-05	0.00124	CbGpPWpGaD
Losartan—ALB—Selenium Micronutrient Network—IL1B—atopic dermatitis	3.34e-05	0.0012	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—CXCL8—atopic dermatitis	3.32e-05	0.0012	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—GLB1—atopic dermatitis	3.25e-05	0.00117	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.23e-05	0.00117	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CCL11—atopic dermatitis	3.22e-05	0.00116	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CMA1—atopic dermatitis	3.22e-05	0.00116	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—IL1B—atopic dermatitis	3.19e-05	0.00115	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—IL2—atopic dermatitis	3.17e-05	0.00115	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	3.14e-05	0.00113	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—CXCL10—atopic dermatitis	3.14e-05	0.00113	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	3.12e-05	0.00113	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—ADSL—atopic dermatitis	3.11e-05	0.00112	CbGpPWpGaD
Losartan—SLCO1B3—Transmembrane transport of small molecules—PPARA—atopic dermatitis	3.07e-05	0.00111	CbGpPWpGaD
Losartan—ALB—Folate Metabolism—TNF—atopic dermatitis	3.05e-05	0.0011	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—STAT6—atopic dermatitis	3.02e-05	0.00109	CbGpPWpGaD
Losartan—ALB—Vitamin B12 Metabolism—IL6—atopic dermatitis	3.02e-05	0.00109	CbGpPWpGaD
Losartan—ACE—Metabolism of proteins—CXCL8—atopic dermatitis	3.02e-05	0.00109	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—GLB1—atopic dermatitis	2.97e-05	0.00107	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—CCL5—atopic dermatitis	2.97e-05	0.00107	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—CXCL8—atopic dermatitis	2.86e-05	0.00103	CbGpPWpGaD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	2.85e-05	0.00103	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—ADSL—atopic dermatitis	2.85e-05	0.00103	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	2.84e-05	0.00103	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	2.84e-05	0.00103	CbGpPWpGaD
Losartan—ALB—Hemostasis—SELE—atopic dermatitis	2.83e-05	0.00102	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—CCL5—atopic dermatitis	2.7e-05	0.000975	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—CCR5—atopic dermatitis	2.68e-05	0.000967	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	2.67e-05	0.000964	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CCR3—atopic dermatitis	2.62e-05	0.000947	CbGpPWpGaD
Losartan—ALB—Folate Metabolism—IL6—atopic dermatitis	2.46e-05	0.000888	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—CCR5—atopic dermatitis	2.43e-05	0.000878	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	2.43e-05	0.000878	CbGpPWpGaD
Losartan—ALB—Selenium Micronutrient Network—TNF—atopic dermatitis	2.42e-05	0.000874	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TAC1—atopic dermatitis	2.34e-05	0.000844	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—NPS—atopic dermatitis	2.34e-05	0.000844	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—TNF—atopic dermatitis	2.31e-05	0.000835	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	2.3e-05	0.00083	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CXCR3—atopic dermatitis	2.29e-05	0.000827	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—PPARA—atopic dermatitis	2.27e-05	0.000818	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—IL5—atopic dermatitis	2.17e-05	0.000784	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.17e-05	0.000783	CbGpPWpGaD
Losartan—ALB—Hemostasis—IL5—atopic dermatitis	2.15e-05	0.000775	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	2.13e-05	0.000769	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	2.07e-05	0.000749	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	2.06e-05	0.000744	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—GLB1—atopic dermatitis	1.97e-05	0.000713	CbGpPWpGaD
Losartan—ALB—Selenium Micronutrient Network—IL6—atopic dermatitis	1.95e-05	0.000705	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—ADSL—atopic dermatitis	1.89e-05	0.000683	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CXCL10—atopic dermatitis	1.85e-05	0.000669	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GLB1—atopic dermatitis	1.71e-05	0.000617	CbGpPWpGaD
Losartan—ALB—Metabolism—GLB1—atopic dermatitis	1.7e-05	0.000614	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ADSL—atopic dermatitis	1.64e-05	0.000592	CbGpPWpGaD
Losartan—ALB—Metabolism—ADSL—atopic dermatitis	1.63e-05	0.000588	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—CXCL8—atopic dermatitis	1.62e-05	0.000585	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CCL5—atopic dermatitis	1.59e-05	0.000576	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	1.59e-05	0.000574	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—IL2—atopic dermatitis	1.55e-05	0.000559	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GLB1—atopic dermatitis	1.53e-05	0.000551	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PPARA—atopic dermatitis	1.52e-05	0.000551	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GLB1—atopic dermatitis	1.49e-05	0.000538	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—NGF—atopic dermatitis	1.48e-05	0.000533	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—CXCL8—atopic dermatitis	1.47e-05	0.000531	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ADSL—atopic dermatitis	1.46e-05	0.000528	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	1.44e-05	0.000521	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PPARA—atopic dermatitis	1.44e-05	0.000519	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CCR5—atopic dermatitis	1.44e-05	0.000519	CbGpPWpGaD
Losartan—ABCB1—Metabolism—ADSL—atopic dermatitis	1.43e-05	0.000516	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—IL2—atopic dermatitis	1.4e-05	0.000507	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GLB1—atopic dermatitis	1.39e-05	0.000502	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ADSL—atopic dermatitis	1.33e-05	0.000482	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PPARA—atopic dermatitis	1.3e-05	0.000468	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.25e-05	0.00045	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.24e-05	0.000447	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—NFKBIA—atopic dermatitis	1.22e-05	0.00044	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GLB1—atopic dermatitis	1.19e-05	0.000429	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.18e-05	0.000425	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.14e-05	0.000412	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ADSL—atopic dermatitis	1.14e-05	0.000412	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.11e-05	0.000402	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PPARA—atopic dermatitis	1.05e-05	0.00038	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.03e-05	0.000373	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.01e-05	0.000366	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PPARA—atopic dermatitis	9.65e-06	0.000349	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GLB1—atopic dermatitis	9.18e-06	0.000331	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ADSL—atopic dermatitis	8.8e-06	0.000318	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CXCL8—atopic dermatitis	8.68e-06	0.000314	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	8.66e-06	0.000313	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—IL2—atopic dermatitis	8.3e-06	0.0003	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—IL6—atopic dermatitis	8.26e-06	0.000298	CbGpPWpGaD
Losartan—ALB—Hemostasis—IL2—atopic dermatitis	8.2e-06	0.000296	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MAPK8—atopic dermatitis	7.64e-06	0.000276	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PPARA—atopic dermatitis	6.41e-06	0.000231	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PPARA—atopic dermatitis	5.55e-06	0.0002	CbGpPWpGaD
Losartan—ALB—Metabolism—PPARA—atopic dermatitis	5.52e-06	0.000199	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PPARA—atopic dermatitis	4.95e-06	0.000179	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—IL6—atopic dermatitis	4.88e-06	0.000176	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PPARA—atopic dermatitis	4.83e-06	0.000175	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PPARA—atopic dermatitis	4.52e-06	0.000163	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PPARA—atopic dermatitis	3.86e-06	0.000139	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PPARA—atopic dermatitis	2.98e-06	0.000108	CbGpPWpGaD
